Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1

Affiliations

• ¹ Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ² Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
• ³ Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
• ⁴ Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
• ⁵ Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
• ⁶ Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ⁷ Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.